These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3415720)

  • 1. Absorption of tranexamic acid as a prodrug in healthy volunteers.
    Svahn CM; Schannong M; Stenberg U; Widlund L
    Arzneimittelforschung; 1988 May; 38(5):735-8. PubMed ID: 3415720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man.
    Puigdellívol E; Carral ME; Moreno J; Plà-Delfina JM; Jané F
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):298-301. PubMed ID: 4018929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys.
    Cundy KC; Annamalai T; Bu L; De Vera J; Estrela J; Luo W; Shirsat P; Torneros A; Yao F; Zou J; Barrett RW; Gallop MA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):324-33. PubMed ID: 15146029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hereditary angioneurotic edema with tranexamic acid and cinnarizine.
    Ohela K
    Acta Derm Venereol; 1976; 56(1):61-7. PubMed ID: 56859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of tranexamic acid to plasma and saliva after oral administration and mouth rinsing: a pharmacokinetic study.
    Sindet-Pedersen S
    J Clin Pharmacol; 1987 Dec; 27(12):1005-8. PubMed ID: 3437064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of tranexamic acid.
    Pilbrant A; Schannong M; Vessman J
    Eur J Clin Pharmacol; 1981; 20(1):65-72. PubMed ID: 7308275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and gastric fibrinolysis in the rat.
    Stenberg B; Risberg B; Peterson HI
    Thromb Haemost; 1980 Feb; 42(5):1425-8. PubMed ID: 7368148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid derivatives with enhanced absorption.
    Svahn CM; Merenyi F; Karlson L; Widlund L; Grälls M
    J Med Chem; 1986 Apr; 29(4):448-53. PubMed ID: 3959024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tranexamic acid (Cyclocapron, Kabi). An antifibrinolytic].
    Storm O
    Ugeskr Laeger; 1975 May; 137(20):1120-1. PubMed ID: 1136002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyklokapron (tranexamic acid) in the treatment of patients with advanced neoplasms].
    Fosså SD; Solheim O; Fosså J
    Tidsskr Nor Laegeforen; 1978 Oct; 98(28):1368-70. PubMed ID: 360480
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffusion of tranexamic acid to the joint.
    Ahlberg A; Eriksson O; Kjellman H
    Acta Orthop Scand; 1976 Oct; 47(5):486-8. PubMed ID: 998182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ulcerative colitis by the direct administration of an antifibrinolytic agent as an enema.
    Kondo M; Hotta T; Takemura S; Yoshikawa T; Fukumoto K
    Hepatogastroenterology; 1981 Oct; 28(5):270-3. PubMed ID: 7047340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of oral [14C]cefcanel daloxate hydrochloride in healthy male subjects.
    Edwall B; Arvidsson A; Lake-Bakaar D; Lanbeck-Vallén K; Yisak W
    Drug Metab Dispos; 1993; 21(1):171-7. PubMed ID: 8095213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of tranexamic acid.
    Astedt B
    Scand J Gastroenterol Suppl; 1987; 137():22-5. PubMed ID: 3321402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of tranexamic acid to influence the ellagic acid-induced hypercoagulable state.
    Girolami A; Cella G; Burul A; Zucchetto M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):261-70. PubMed ID: 61921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of p-hydroxyphenyl-propionic ester of tranexamic acid hydrochloride (Cetraxate) on peptic ulcer. Multi-center clinical study.
    Ishimori A; Yamagata S; Taima T
    Arzneimittelforschung; 1979; 29(10):1625-32. PubMed ID: 391240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tranexamic acid on the fibrinolytic activity of vein walls.
    Astedt B; Liedholm P; Wingerup L
    Ann Chir Gynaecol; 1978; 67(6):203-5. PubMed ID: 742821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of salicin as an antipyretic prodrug that does not cause gastric injury.
    Akao T; Yoshino T; Kobashi K; Hattori M
    Planta Med; 2002 Aug; 68(8):714-8. PubMed ID: 12221594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery.
    Nuttall GA; Gutierrez MC; Dewey JD; Johnson ME; Oyen LJ; Hanson AC; Oliver WC
    J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):230-5. PubMed ID: 18375325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.